Skip to main content
OpenTrials

Clinical trial condition

NMO Spectrum Disorder (NMOSD)

Explore clinical trials studying NMO Spectrum Disorder (NMOSD). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

NMO Spectrum Disorder (NMOSD) trial results

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

NCT02028884

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Hopital de Hautepierre CHRU de Strasbourg Strasbourg, France
  • NeuroCure Clinical Research Center (NCRC) Berlin, Germany
  • St. Josef-Hospital, Klinik für Neurologie Bochum, Germany
View all 40 locations
View Trial Details
Completed

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT02073279

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • University of Colorado Denver -; Neurology Aurora, Colorado, United States
  • University of Miami UHealth Professional Arts Center Miami, Florida, United States
  • The MS Center of Vero Beach Vero Beach, Florida, United States
  • Columbus Research and Wellness Columbus, Georgia, United States
View all 58 locations
View Trial Details

Related conditions